Amphastar Pharmaceuticals Inc vs Huntington Bancshares Incorporated — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Huntington Bancshares Incorporated trades at $17.94 (market cap $35.93B). The key difference: Huntington Bancshares Incorporated is far larger — about 41.4× Amphastar Pharmaceuticals Inc's market cap, and Huntington Bancshares Incorporated pays a 3.49% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | HBAN | |
|---|---|---|
Market Cap | $868.62M | $35.93B |
Sector | Health | Financials |
52-Week High | $30.81 | $19.27 |
52-Week Low | $16.87 | $15.02 |
Enterprise Value | $1.27B | — |
Dividend Yield | — | 3.49% |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →